Journals / Gazi Medical Journal / 2018 / Cilt: 29 - Sayı: 1

Investigation of the Effects of Sevoflurane and Desflurane on Erythrocyte Deformability in Transient Hyperglycemia

Geçici Hiperglisemi anında Sevofluran ve Desfluranın Eritrosit Deformabilitesi Üzerine Etkilerinin Araştırılması

Pages
8–11
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

After 24 hours blood samples were obtained and deformabilitymeasurements were performed in erythrocyte suspensions containing Htc5% in a PBS buffer.Results: Diabetes mellitus was found to increase relative resistance in thecontrol group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Micro and macrovascular complications due to long-term hyperglycemiaare associated with increased mortality and morbidity.
📊
Key Findings & Data:Erythrocytes exposedto hyperglycemia for a long time may cause morphological changes inerythrocytes such as decreased deformability and development ofaggregation.
💡
Conclusion & Impact:After 24 hours blood samples were obtained and deformabilitymeasurements were performed in erythrocyte suspensions containing Htc5% in a PBS buffer.Results: Diabetes mellitus was found to increase relative resistance in thecontrol group (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: Micro and macrovascular complications due to long-term hyperglycemiaare associated with increased mortality and morbidity. Erythrocytes exposedto hyperglycemia for a long time may cause morphological changes inerythrocytes such as decreased deformability and development ofaggregation. As a result, complications such as shortening life span oferythrocytes, impairment of oxygen carrying capacity, tissue hypoxia mayoccur. In our study, we would like to investigate the effects of Sevoflurane andDesflurane on erythrocyte deformability during transient hyperglycemia.Materials and Methods: In this study, 30 male Wistar albino rats were used.The animals were randomly divided into five groups, each contained 6 rats:Diabetic control (group DC), diabetic hyperglycemia group (group DH),diabetic hyperglycemia group with desflurane (group DH-D), and diabetichyperglycemia group with sevoflurane (group DH-S) groups. Another 6 ratswithout diabetes were assigned as control group (group C). Streptozotocin-induced diabetic rats were kept 6 weeks, then transient hyperglycemia wascreated, and the administration of sevoflurane and desflurane wereperformed. After 24 hours blood samples were obtained and deformabilitymeasurements were performed in erythrocyte suspensions containing Htc5% in a PBS buffer.Results: Diabetes mellitus was found to increase relative resistance in thecontrol group (p

Özet

Amaç: Uzun süreli hipergliseminin oluşturduğu mikro ve makrovasküler komplikasyonlar mortalite ve morbidite artışı ile birliktedir. Eritrositlerin ise yaşam süreleri boyunca uzun süre hiperglisemiye maruz kalmaları morfolojik olarak eritrositlerde deformabilitede azalma ve agregasyon gelişmesi gibi bir takım değişikliklere neden olmaktadır. Bunun sonucunda eritrositlerin yaşam sürelerinde kısalma, oksijen taşıma kapasitesinde bozukluk, doku hipoksisi gibi komplikasyonlar meydana gelmektedir. Sevofluran ve desfluranın ise eritrosit deformabilitesi üzerine etkileri ile ilgili çeşitli çalışmalar mevcuttur. Biz de bu çalışmamızda geçici olarak oluşturulan hiperglisemi sırasında sevofluran ve desfluranın eritrosit deformabilitesi üzerine etkilerini araştırmayı amaçladık. Yöntem: Çalışma Gazi Üniversitesi Deneysel ve Klinik Araştırma Merkezi'nde Gazi Üniversitesi Deney Hayvanları Etik Kurulu onayı ile yapıldı. Çalışmaya 30 rat dahil edildi. Ratlar; kontrol grubu, diyabetik-kontrol, diyabetik hiperglisemi, diyabetik–hiperglisemi-sevofluran, diyabetik-hiperglisemi- desfluran olmak üzere 5 gruba ayrıldı. Streptozosin ile diyabet oluşturulan ratlar 6 hafta yaşatıldıktan sonra geçici hipergilisemi oluşturuldu ve sevofluran ve desfluran anestezisi uygulandı. 24 saat sonra kan örnekleri alındı ve santrifüj edildi. Eritrosit deformabilitesi sabit akım filtrometre sistemleri kullanılarak ölçüldü. Rölatif rezistansının artması eritrosit deformabilitesinin azalması olarak yorumlandı. Bulgular: Diyabet oluşturulmasının kontrol grubuna göre rölatif rezistansı arttırdığı bulundu (p

🔖

Cite This Article

GÜNEŞ, I., KURTİPEK, Ö., ÇOMU, F. M., DİKMEN, B., KALAYCİ, D., BEŞKARDEŞ, E., ARPACİ, A. H., ARSLAN, M. (2022). Investigation of the Effects of Sevoflurane and Desflurane on Erythrocyte Deformability in Transient Hyperglycemia. Gazi Medical Journal, Cilt: 29 - Sayı: 1, 8–11. https://ajindex.com/articles/519797

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Diabetes Atlas 2003.
  2. International Diabetes Federation, Brussels, 2003.
  3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–53.
  4. Watala C, Zawodniak M, Bryszewska M, Nowak S. Nonenzymatic protein glycosylation. I. Lowered erythrocyte membrane fluidity in juvenile diabetes. Ann Clin Res 1985;17:327–30.
  5. Cohen RM, Franco RS, Khera PK, Smith EP, Lindsell CJ, Ciraolo PJ, et al. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c. Blood 2008;112:4284-91.
  6. Fujita J, Tsuda K, Takeda T, Yu L, Fujimoto S, Kajikawa M, et al. Nisoldipine improves the impaired erythrocyte deformability correlating with elevated intracellular free calcium-ion concentration and poor glycaemic control in NIDDM. Br J Clin Pharmacol 1999;47:499-506.
  7. Bareford D, Jennings PE, Stone PC, Baar S, Barnett AH, Stuart J. Effects of hyperglycaemia and sorbitol accumulation on erythrocyte deformability in diabetes mellitus. J Clin Pathol 1986;39:722-7.
  8. Symeonidis A, Athanassiou G, Psiroyannis A, Kyriazopoulou V, Kapatais- Zoumbos K, Missirlis Y, et al. Impairment of erythrocyte viscoelasticity is correlated with levels of glycosylated haemoglobin in diabetic patients. Clin Lab Haematol 2001;23:103-9.
  9. Erdogan C, Erdem A, Akıncı SB, Dikmenoglu N, Basgül E, Balkancı D, et al. The effects of midazolam on erythrocyte deformability and plasma viscosity in rats. Anestezi Dergisi. 2005;13:205–8.
  10. Muller R, Musikic P. Hemorheology in surgery: A review. Angiology. 1987;38:581-92. Dormandy JA. Effects of anaesthesia and surgery on the flow properties of blood. Microcirc Endothelium Lymphatics 1984;1:151-68.
  11. Robertshaw HJ, Hall GM. Diabetes mellitus: anaesthetic management. Anaesthesia 2006; 61:1187–90.
  12. McAnulty GR, Robertshaw HJ, Hall GM. Anaesthetic management of patients with diabetes mellitus. Br J Anesth 2000; 85: 80–90.
  13. McAnulty GR, Hall GM. Anaesthesia for the diabetic patient. Br J Anesth 2003; 88: 428–30 Loomans CJ, de Koning EJ, Staal FJ, Rookmaaker MB, Verseyden C, de Boer HC, et al. Endothelial progenitor cell dysfunction; a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004;53:195-9.
  14. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology and management. JAMA 2002;287:2570-25.
  15. Yeom E, Byeon H, Lee SJ. Effect of diabetic duration on hemorheological properties and platelet aggrega